Infectious Disease
Tinea Capitis
0
Pipeline Programs↗
2
Active Trials↗
1
Companies Involved↗
Tinea Capitis is an early-stage landscape with 0 programs across 1 company. The most active players are Novartis.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
6
clinical trials
Completed4 · 67%
Recruiting2 · 33%
Clinical Trials
Trial Activity
6 trials
Comparison Between Continuous and Pulse Itraconazole in Tinea Capitis in Children
Recruiting·—·N/A·NCT07184203·120 enrolled
Efficacy Comparison of Itraconazole Pulse Therapy and Terbinafine Therapy in Treatment of Tinea Capitis in Children.
Completed·—·N/A·NCT07068256·164 enrolled
Selenium Sulfide, Ketoconazole and Ciclopirox Shampoo as Additional Treatments for Tinea Capitis (Scalp Ringworm)
Completed·—·N/A·NCT00127868·47 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)